Arax Advisory Partners’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q4
Sell
-20
Closed -$365 2795
2024
Q3
$365 Hold
20
﹤0.01% 2447
2024
Q2
$327 Buy
+20
New +$327 ﹤0.01% 2387